03 August 2017 | Geneva –– The first free, on-line course on a neglected tropical disease is now available to the public.
The course on post-kala-azar dermal leishmaniasis (PKDL) aims to help health workers and field practitioners recognize this form of the disease which is often misdiagnosed. Anyone completing the course with a minimum score of 70% will be awarded a certificate.
26 June 2017 | Geneva | Nairobi ––The World Health Organization (WHO) has dispatched medical supplies to Kenya in response to an outbreak of visceral leishmaniasis in Marsabit County, with a population of over 290 000.
According to local media, four people have died as a result of this outbreak.
11 November 2016 | New Delhi | Geneva –– Three countries that were once highly endemic for visceral leishmaniasis are poised to eliminate the disease as a public health problem by 2020.
Bangladesh, India and Nepal have lowered the number of new cases and as the three countries approach elimination, WHO's Regional Office for South-East Asia has published the process to validate the elimination of this form of leishmaniasis.
27 September 2016 ¦ Geneva –– The World Health Organization (WHO) and Gilead Sciences have signed a new agreement that allows the pharmaceutical company to donate medicines for the treatment of visceral leishmaniasis.
Under the new 5-year collaboration and until 2021, Gilead Sciences have also agreed to provide financial assistance for the expansion of leishmaniasis surveillance and control.
Visceral leishmaniasis is endemic in more than 80 countries worldwide.
14 July 2016 | Geneva −−The World Health Organization (WHO) is leading an effort to leverage routine leishmaniasis surveillance data from 25 high-burden countries from WHO regions to create new profiles.
The data include breakdown of new, relapse and imported cases; populations at risk; control and surveillance (including latest national guidelines, number of leishmaniasis health facilities), diagnosis (such as number of people screened, proportion of positive rapid diagnostic tests) and treatment including initial cure and case-fatality rates.
- Manual on case management and surveillance of the leishmaniases in the WHO European Region
- Accelerated plan for kala-azar elimination (2017)
- Process of validation of elimination of kala-azar as a public health problem in South-East Asia
Neglected tropical diseases course now accessible via eLearning
WHO responds to visceral leishmaniasis outbreak in Kenya
Visceral leishmaniasis: WHO publishes validation document as countries approach elimination
WHO and Gilead Sciences extend collaboration against visceral leishmaniasis
Upcoming events & meetings
Explore some of the issues surrounding visceral leishmaniasis in Africa and in India, and cutaneous leishmaniasis in South America. Watch the trailer of "A trilogy of injustice"